Time & Location
September 6, 2018 at 10:00 am
Venue: Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Beutenbergstraße 11
Jena/Germany
Content
Often, conferences focus on science and the PIs, usually allowing only a secondary role to junior researchers. The Non-PI Meeting "Jena Aging Seminar (JAS)" intends to put the junior researchers at the forefront of the conference. The JAS Meeting is meant as a workshop for career guidance for PhD Students and Postdocs. In order to foster a mood of openness, the JAS is organized by a group of young researchers from the Leibniz Institute on Aging (FLI).
The JAS Non-PI Meeting will take place on the opening morning at the FLI in Jena.This accommodates a meeting of young scientists in an environment well eqipped for meetings, but also allows participants to see a world-leading aging institute from within.
4 academic speakers of differing levels of seniority and 2 non-academic speakers from industry will be invited. Each speaker will host an intimate round-table discussion with 5-6 young scientits. These will last 20-25 minutes and the participants will move in their small groups from speaker to speaker.
Invited Speakers from Research & Academics
Claudia Waskow, Leibniz Institute on Aging (FLI) in Jena, Germany, and TU Dresden, Germany
Claudia Waskow is a senior scientist and has been a Professor for Regeneration in Hematopoiesis since 2014. She has been awarded numerous grants and she is recognized for her contribution to Immunology and Hematopoiesis. Her successful career and senior position make her a role model and mentor for researchers and especially women in science.
Alessandro Ori, Leibniz Institute on Aging (FLI) Jena, Germany
Alessandro Ori joined the Leibniz Institute on Aging (FLI) in Jena, Germany, as a Junior Group Leader. He is interested in the Proteomics of Aging and the integration and analysis of proteomic data with genomic information. Young researchers would benefit from his advice because he can draw on his fast-track career progession experience.
Kristina Kirschner, University of Glasgow, UK
Kristina Kirschner is currently a Wellcome Trust ISSF Fellow in the Institute for Cancer Sciences in the University of Glasgow, United Kingdom since 2016. Her interest lies in hematopoietic stem cells in aging and leukemia using single cell transcriptomic approaches. Her experiences and her career progression would be ideal for young researchers trying to identify their next career steps.
Invited Speakers from Industry
Marcus Kostka, Boehringer Ingelheim Corporate Venture Found, Germany
Marcus Kostka is Director of the Boehringer Ingelheim Corporate Venture Fund. Since beginning of 2014, he has been working in the Boehringer Ingelheim Venture team in Ingelheim. He serves as board member of Rigontec in Bonn and eTheRNA in Brussels. Marcus studied Biology with a focus on Genetics and Biochemistry in Münster and Mainz. His vast research to industry experience makes Marcus an ideal industry representative.
Peter Florian, Sanofi-Aventis, Germany
Peter Florian is currently working as an in-vivo pharmacologist and head of the pharmacology section at Sanofi with an additional focus on translational research aspects dealing with chronic inflammatory diseases using biotherapeutical treatment approaches. Peter is an experienced translational researcher with many years of Biotech know-how.
Registration
For registration, please use the JAS-registration form.
Please note: Registration for JAS is only valid in combination with the JAM-conference registration!
